217 related articles for article (PubMed ID: 25120803)
1. Bromodomain 4 protein is a predictor of survival for urothelial carcinoma of bladder.
Yan Y; Yang FQ; Zhang HM; Li J; Li W; Wang GC; Che JP; Zheng JH; Liu M
Int J Clin Exp Pathol; 2014; 7(7):4231-8. PubMed ID: 25120803
[TBL] [Abstract][Full Text] [Related]
2. Argonaute 2 is up-regulated in tissues of urothelial carcinoma of bladder.
Yang FQ; Huang JH; Liu M; Yang FP; Li W; Wang GC; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(1):340-7. PubMed ID: 24427355
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder.
Liu JY; Li YH; Lin HX; Liao YJ; Mai SJ; Liu ZW; Zhang ZL; Jiang LJ; Zhang JX; Kung HF; Zeng YX; Zhou FJ; Xie D
BMC Cancer; 2013 Jul; 13():349. PubMed ID: 23870412
[TBL] [Abstract][Full Text] [Related]
4. Protein phosphatase-2A is down-regulated in patients within clear cell renal cell carcinoma.
Li J; Sheng C; Li W; Zheng JH
Int J Clin Exp Pathol; 2014; 7(3):1147-53. PubMed ID: 24696731
[TBL] [Abstract][Full Text] [Related]
5. Sp1 is overexpressed and associated with progression and poor prognosis in bladder urothelial carcinoma patients.
Zhu J; Lu Z; Ke M; Cai X
Int Urol Nephrol; 2022 Jul; 54(7):1505-1512. PubMed ID: 35467245
[TBL] [Abstract][Full Text] [Related]
6. CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.
Xue Y; Wu G; Wang X; Zou X; Zhang G; Xiao R; Yuan Y; Long D; Yang J; Wu Y; Xu H; Liu F; Liu M
Med Oncol; 2013 Mar; 30(1):406. PubMed ID: 23275123
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer.
Ruan J; Wei B; Xu Z; Yang S; Zhou Y; Yu M; Liang J; Jin K; Huang X; Lu P; Cheng H
Med Oncol; 2013 Mar; 30(1):445. PubMed ID: 23307254
[TBL] [Abstract][Full Text] [Related]
8. Bromodomain protein 4 is a novel predictor of survival for gastric carcinoma.
Zhu Y; Yang W; Ji G; Lin N; Wu W; Xiong P; Zheng C; Yan L; Wan P; Wang Y
Oncotarget; 2017 May; 8(19):31092-31100. PubMed ID: 28415703
[TBL] [Abstract][Full Text] [Related]
9. High expression of Cdc25B and low expression of 14-3-3σ is associated with the development and poor prognosis in urothelial carcinoma of bladder.
Zhang Z; Zhang G; Kong C
Tumour Biol; 2014 Mar; 35(3):2503-12. PubMed ID: 24234332
[TBL] [Abstract][Full Text] [Related]
10. PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway.
Liu JY; Qian D; He LR; Li YH; Liao YJ; Mai SJ; Tian XP; Liu YH; Zhang JX; Kung HF; Zeng YX; Zhou FJ; Xie D
Mol Cancer; 2013 Nov; 12(1):148. PubMed ID: 24268029
[TBL] [Abstract][Full Text] [Related]
11. Low expression of TMEM67 is a critical predictor of poor prognosis in human urothelial carcinoma of the bladder.
Du E; Zhang C; Qin Z; Yang K; Li C; Wang A; Zhang Z; Xu Y
Urol Oncol; 2017 Apr; 35(4):152.e7-152.e12. PubMed ID: 28161324
[TBL] [Abstract][Full Text] [Related]
12. Correlations of Foxo3 and Foxo4 expressions with clinicopathological features and prognosis of bladder cancer.
Wang Y; Kang XL; Zeng FC; Xu CJ; Zhou JQ; Luo DN
Pathol Res Pract; 2017 Jul; 213(7):766-772. PubMed ID: 28554751
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.
Boman K; Segersten U; Ahlgren G; Eberhard J; Uhlén M; Jirström K; Malmström PU
BMC Urol; 2013 Apr; 13():17. PubMed ID: 23565664
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder.
Chen X; Wu B; Xu Z; Li S; Tan S; Liu X; Wang K
Cancer Med; 2016 Aug; 5(8):1856-62. PubMed ID: 27292588
[TBL] [Abstract][Full Text] [Related]
15. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC
Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of TRPM8 is associated with poor prognosis in urothelial carcinoma of bladder.
Xiao N; Jiang LM; Ge B; Zhang TY; Zhao XK; Zhou X
Tumour Biol; 2014 Nov; 35(11):11499-504. PubMed ID: 25128062
[TBL] [Abstract][Full Text] [Related]
17. Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder.
Bi J; Chen X; Zhang Y; Li B; Sun J; Shen H; Kong C
Urol Oncol; 2012 Sep; 30(5):688-94. PubMed ID: 20888270
[TBL] [Abstract][Full Text] [Related]
18. Expression of beclin 1 in bladder cancer and its clinical significance.
Liu GH; Zhong Q; Ye YL; Wang HB; Hu LJ; Qin ZK; Zeng MS; Zeng BH
Int J Biol Markers; 2013 Apr; 28(1):56-62. PubMed ID: 23125008
[TBL] [Abstract][Full Text] [Related]
19. Complete loss of STAG2 expression is an indicator of good prognosis in patients with bladder cancer.
Qiao Y; Zhu X; Li A; Yang S; Zhang J
Tumour Biol; 2016 Aug; 37(8):10279-86. PubMed ID: 26838030
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomy.
Liu A; Xue Y; Liu F; Tan H; Xiong Q; Zeng S; Zhang Z; Gao X; Sun Y; Xu C
Cancer Biomark; 2019; 26(3):281-289. PubMed ID: 31594208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]